Drug-induced localized lipodystrophy

MONDO:0019553

Drug-induced localized lipodystrophy is a rare, acquired, localized lipodystrophy characterized by the appearance of asymptomatic, well-demarcated, variably sized, depressed, lipoatrophic lesions secondary to subcutaneous, intradermic or intramuscular drug injection, including corticosteroids, insulin, human growth hormone and antibiotics. Skin coloration may vary from white or hypopigmented to reddish, pinkish or violaceous. Epidermal atrophy may be also present.

Also known as: lipoatrophy caused by injected drug

22 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Sort by